Purpose: To report a case of retinal vascular tumor and to review literature pertaining to management of retinal vascular tumors of the eye. Methods: Clinical data including medical history, findings on physical examination, local examination, Fundus Fluorescein Angiography, USG B-Scan, MR Angiography of head and orbit was done for a 31 year old male, case of retinal juxtapapillary hemangioblastoma. Patient was given 2 injections of intravitreal Anti-VEGF at 4 weeks interval to reduce tumor vascularity, size and associated exudation, oedema and SRF to improve visual acuity. PDT was done following this for the residual tumor mass. Results: Visual acuity of the patient improved from finger counting at 3mts to 6/24 following intravitreal injections. Following PDT vision further improved to 6/18 and was maintained at that. No new tumor activity was observed over next 6 months. Conclusions:Combination of Anti-VEGF and PDT is an effective method of treatment of juxtrapapillary hemangioblastomas and of improving and preserving vision of the patient.

Dear Editor,Retinal vein occlusion is a major cause of retinal vascular disease, second to diabetic retinopathy. Branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) are the two major categories both have potential for loss of vision owing to complications causing macular edema and neovascularization. Many reports suggest hyperhomocysteinaemia is a risk factor for vascular occlusion. This may be related to increasing plasma homocysteine levels, or more probably to homodynamic change or local vascular insult. We report a case of 76 year old male patient presented with painless sudden loss of vision both eyes. He was not hypertensive (physician opinion was undertaken and all routine blood investigations were found to be within normal limits including hemogram, platelet count, ESR), non diabetic, non -alcoholic and occasional smoker. No past history of drug intake or cardiac illness was seen. Systemic Examination revealed no abnormalities. At presentation his visual acuity was finger counting at 3 meters in both eyes; his intraocular pressure was 16mm Hg in both eyes by applanation tonometer. Anterior segment examination was unremarkable except for early lenticular opacity in both eyes.Fundus examination revealed both eyes having central vein occlusion with well demarcated hemorrhages and edema along vessels (Figure 1). Macular OCT revealed increased thickness of macula (left more than right) with VMMC and Safdarjung Hospital New Delhi

Aim:To study the effectiveness of atropine in retarding progressive axial myopia in the age group 5 to 15. Materials and Methods:This prospective interventional cohort study included children aged 5-15 years. Both the eyes of myopic children with progressive increase of ≥−0.5D sphere/year with the best-corrected vision of ≥6/6 were treated with once a day application of 0.01% atropine eye drops. The progression of myopia after 1-year follow-up was analyzed.Outcome measures: Outcome was measured by the visual acuity using snellens chart every month till 12 months.Results: 50 eyes of 25 myopes were included in the study. The mean age was 10 years. The mean baseline sphere was −5.0D. Duration of follow-up was12 months. The baseline rate of progression was reduced from −0.8D/year (range −0.5D/year to −3D/year) to −0.1D/year (range 0D/year to −1.0D/year) after atropine therapy. Conclusion:Atropine eye drops was well tolerated and efficacious for the retardation of progressive myopia.

Aim: The purpose of this study was to study the epidemiology of glaucoma in a semi urban population of delhi.Methods: 24651 patients attending the eye OPD of Attar Sain Jain Eye and General Hospital, Govt of NCT of Delhi were screened and treated for glaucoma over a period of 6 months-from 1st July to 31st December, 2013. Results:Total of 261 cases of all types of glaucoma was identified. Out of these 43 were angle closure glaucoma and 218 were open angle glaucoma. Newer cases diagnosed were 118(78 of open angle glaucoma and 30 of angle closure glaucoma). Thus the overall incidence was 4.79 cases per 1000 population. Overall prevalence of glaucoma was 10.59 cases per 1000 population. The overall male to female distribution was 121 male cases to 140 female cases but this figure was skewed towards 30 females to 13 males in case of angle closure. Family history for glaucoma was positive in 73 percent of all cases (191 cases). Two cases required surgery and 32 cases required laser iridotomy (new and augumentation). 62 percent of the overall patients were diabetics and 32 percent were smokers. Conclusion:Glaucoma is one of the leading causes of blindness in the world and India and is a silent killer of the eye. There is a lack of glaucoma epidemiological and risk factor studies and more such studies are required with larger population base and longer duration to have an assessment of the burden of glaucoma. Initiatives to increase public awareness and comprehensive eye examinations by ophthalmologists are the key to reducing or eliminating undiagnosed glaucoma. If all ophthalmologists perform comprehensive eye examinations (that includes basic slitlamp examination, intraocular pressure (IOP) measurement, pachymetry, gonioscopy and dilated fundus examination), we can definitely minimize under-diagnosis.

No abstract